ATS PC Assembly

The ATS Fellows 2026 Program application is open! This prestigious recognition is awarded to ATS members who have demonstrated excellence, dedication, leadership, and significant contributions to their field. Applications close Aug. 31 — apply today! site.thoracic.org/membership/ats…

📢WSPH Association is proud and happy to announce that the next World Symposium on Pulmonary Hypertension will be held in Amsterdam on July 1-4, 2029. Stay tuned for more details!📢 #WSPH2029 #WSPH #WSPHAssociation #PAH

LncRNA-536 sequesters RBM25, suppresses HOXB13 and promotes vascular smooth muscle proliferation, revealing new insight into PH ahajrnls.org/44PLG4H

Stay sharp with curated summaries of recent pulmonary embolism research - reviewed by members of The Consortium. Dr. Michael Karass wrote his latest PERTspective on "Development and implementation of an emergency alteplase kit for high-risk pulmonary embolism in cardiac arrest."…

STING signaling pathway in PAH! JCI Insight - Opposing roles for myeloid and smooth muscle cell STING in pulmonary hypertension @ajbryantlab @PVRI @atscommunity @accpchest insight.jci.org/articles/view/…

📢 New publication: Survival Outcomes and Impact of Targeted PAH Therapy in Portopulmonary Hypertension in the PVRI GoDeep Meta-Registry by Arun Jose, Athiththan Yogeswaran, Khodr Tello, @ElwingJean, Werner Seeger, Meike Fünderich Et al. Read the full research article…

Apply to attend our upcoming Academy of pulmonary hypertension! 📆 20–21 November, 2025 📌 Amsterdam, Netherlands The course will identify the different processes involved in diagnosing and managing #pulmonary hypertension. Apply before 21 July: bit.ly/41C3pey

The Impact of Cardiac Output Methods on the Classification of Pulmonary Hypertension doi.org/10.1002/pul2.7…

Cancún + cutting-edge science? I’m in! Next week at #ALAT2025, I’ll be presenting the Year in Review in Pulmonary Circulation, spotlighting the studies that shaped the year and why they matter now. Let’s move the field forward… together! ✈️🌊🎙️ @ALATorax @ATS_PC @UTHealthSA

Treatment With Oral or Inhaled Treprostinil in Patients With Pulmonary Arterial Hypertension and Cardiovascular Comorbidities - CHEST @ValMcLaughlinMD journal.chestnet.org/article/S0012-…

🚨 The wait is over — registration and abstract submissions are officially open for #PVRI2026 With the theme of Celebrating 20 Years of Progress & Innovation, join us in Dublin from 28 January – 1 February for world-class science, dynamic discussions, and impactful networking…

New publication: Safety and Immediate Efficacy of Pulmonary Thromboendarterectomy for Chronic Thromboembolic Disease @ucsdpccm @AtulMalhotra13 @loridanielsmd @AnnaMcDivitMD @DrPhreaner @DrTimFernandes @PRETORIUSDr @KimKerrMD @JennyYangMD @UCSDCardFellows sciencedirect.com/science/articl…

Viewpoint: a critique of pulmonary vascular resistance to define severe pulmonary hypertension publications.ersnet.org/content/erj/65…

Hot off the press - Ambient air pollution exposure and mortality in the @PHAssociation registry. @atscommunity @ATS_PC atsjournals.org/doi/abs/10.151…

Next in our High Altitude webinar series 'Hypoxia in Pulmonary Vascular Research – Altitude and Beyond'🗻 📅 1 July 2025 | 1PM BST 🎙️ Join @DrRahulKumarPhD as he explores the role of inflammatory immune cells in hypoxic pulmonary hypertension. Moderated by @aastha_mishra06 &…

Positioning Imatinib for Pulmonary Arterial Hypertension: A Dose-Finding Phase 2 Study @atscommunity #PAH 🔓Open Access 🔗atsjournals.org/doi/full/10.11…